174 related articles for article (PubMed ID: 38794349)
1. Formulation of Ascorbic Acid and Betaine-based Therapeutic Deep Eutectic System for Enhanced Transdermal Delivery of Ascorbic Acid.
Song JE; Jun SH; Ryoo JY; Kang NG
Pharmaceutics; 2024 May; 16(5):. PubMed ID: 38794349
[TBL] [Abstract][Full Text] [Related]
2. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
Aroso IM; Silva JC; Mano F; Ferreira AS; Dionísio M; Sá-Nogueira I; Barreiros S; Reis RL; Paiva A; Duarte AR
Eur J Pharm Biopharm; 2016 Jan; 98():57-66. PubMed ID: 26586342
[TBL] [Abstract][Full Text] [Related]
3. Eutectic solutions for healing: a comprehensive review on therapeutic deep eutectic solvents (TheDES).
Kalantri S; Vora A
Drug Dev Ind Pharm; 2024 May; 50(5):387-400. PubMed ID: 38634708
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
[TBL] [Abstract][Full Text] [Related]
5. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies.
Duarte AR; Ferreira AS; Barreiros S; Cabrita E; Reis RL; Paiva A
Eur J Pharm Biopharm; 2017 May; 114():296-304. PubMed ID: 28189620
[TBL] [Abstract][Full Text] [Related]
6. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen.
Silva E; Oliveira F; Silva JM; Matias A; Reis RL; Duarte ARC
Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33233659
[TBL] [Abstract][Full Text] [Related]
7. A Novel Eutectic-Based Transdermal Delivery System for Risperidone.
Al-Akayleh F; Adwan S; Khanfar M; Idkaidek N; Al-Remawi M
AAPS PharmSciTech; 2020 Nov; 22(1):4. PubMed ID: 33221990
[TBL] [Abstract][Full Text] [Related]
8. Properties of Therapeutic Deep Eutectic Solvents of l-Arginine and Ethambutol for Tuberculosis Treatment.
Santos F; P S Leitão MI; C Duarte AR
Molecules; 2018 Dec; 24(1):. PubMed ID: 30586896
[TBL] [Abstract][Full Text] [Related]
9. Solids Turn into Liquids-Liquid Eutectic Systems of Pharmaceutics to Improve Drug Solubility.
Sarraguça MC; Ribeiro PRS; Nunes C; Seabra CL
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337077
[TBL] [Abstract][Full Text] [Related]
10. Eutectic-based liposome as a potential delivery system of paeonol.
Wu J; Yang S; Yin T; Wang X
RSC Adv; 2021 Dec; 11(62):39343-39348. PubMed ID: 35492495
[TBL] [Abstract][Full Text] [Related]
11. Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system.
Li S; Culkin A; Jones DS; Andrews GP
Int J Pharm; 2021 Jan; 593():120071. PubMed ID: 33246048
[TBL] [Abstract][Full Text] [Related]
12. Towards a greater understanding of the deep eutectic phenomenon through examination of the lidocaine-NSAID therapeutic deep eutectic systems.
Li S; Abdelquader MM; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2024 Jul; 200():114329. PubMed ID: 38761870
[TBL] [Abstract][Full Text] [Related]
13. Novel betaine-amino acid based natural deep eutectic solvents for enhancing the enzymatic hydrolysis of corncob.
Liang Y; Duan W; An X; Qiao Y; Tian Y; Zhou H
Bioresour Technol; 2020 Aug; 310():123389. PubMed ID: 32335347
[TBL] [Abstract][Full Text] [Related]
14. 3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin.
Iliopoulos F; Sil BC; Moore DJ; Lucas RA; Lane ME
Int J Pharm X; 2019 Dec; 1():100025. PubMed ID: 31517290
[TBL] [Abstract][Full Text] [Related]
15. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR
Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248
[TBL] [Abstract][Full Text] [Related]
16. Novel amorphous solid dispersion based on natural deep eutectic solvent for enhancing delivery of anti-tumor RA-XII by oral administration in rats.
Liu M; Lai Z; Zhu L; Ding X; Tong X; Wang Z; Bi Q; Tan N
Eur J Pharm Sci; 2021 Nov; 166():105931. PubMed ID: 34256100
[TBL] [Abstract][Full Text] [Related]
17. Selecting Excipients Forming Therapeutic Deep Eutectic Systems-A Mechanistic Approach.
Wolbert F; Brandenbusch C; Sadowski G
Mol Pharm; 2019 Jul; 16(7):3091-3099. PubMed ID: 31095911
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications.
Abdelquader MM; Li S; Andrews GP; Jones DS
Eur J Pharm Biopharm; 2023 May; 186():85-104. PubMed ID: 36907368
[TBL] [Abstract][Full Text] [Related]
19. Deep eutectic solvent self-assembled reverse nanomicelles for transdermal delivery of sparingly soluble drugs.
Li B; Jiao S; Guo S; Xiao T; Zeng Y; Hu Y; Li X; Xiong S; Xu Y
J Nanobiotechnology; 2024 May; 22(1):272. PubMed ID: 38773580
[TBL] [Abstract][Full Text] [Related]
20. Production of Electrospun Fast-Dissolving Drug Delivery Systems with Therapeutic Eutectic Systems Encapsulated in Gelatin.
Mano F; Martins M; Sá-Nogueira I; Barreiros S; Borges JP; Reis RL; Duarte ARC; Paiva A
AAPS PharmSciTech; 2017 Oct; 18(7):2579-2585. PubMed ID: 28236268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
